Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Stifel analyst Dae Gon Ha downgraded the rating for Editas Medicine, Inc. EDIT from Buy to Hold and lowered the price target from $11 to $3. Editas Medicine shares closed at $1.89 on Thursday. See how other analysts view this stock.
- Mizuho analyst Siti Panigrahi downgraded the rating for RingCentral, Inc. RNG from Outperform to Neutral and maintained the price target of $42. RingCentral shares closed at $41.35 on Thursday. See how other analysts view this stock.
- JP Morgan analyst Michael Rehaut downgraded Toll Brothers, Inc. TOL from Overweight to Neutral and lowered the price target from $166 to $150. Toll Brothers shares closed at $138.46 on Thursday. See how other analysts view this stock.
- Baird analyst Michael Halloran downgraded the rating for Nordson Corporation NDSN from Outperform to Neutral and slashed the price target from $294 to $237. Nordson shares closed at $229.11 on Thursday. See how other analysts view this stock.
- Barclays analyst Brandt Montour downgraded Viking Holdings Ltd VIK from Overweight to Equal-Weight and maintained the price target of $49. Viking Holdings shares closed at $46.18 on Thursday. See how other analysts view this stock.
Considering buying TOL stock? Here’s what analysts think:
Read This Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in